Objectives: Low central venous pressure (LCVP)-assisted hepatectomy is associated with decreased blood loss and lower transfusion rates. Concerns about its impact on renal function have prevented widespread application. This study was conducted to review the dynamics of renal function after LCVP-assisted hepatectomy.
Introduction
Low central venous pressure (LCVP)-assisted liver resection has been practiced at the Memorial Sloan-Kettering Cancer Center (MSKCC) for two decades. 1, 2 This technique, which requires close collaboration between the surgical and anesthesia teams, has proven to be safe and reproducible, and to be of value in reducing the amount of blood loss during hepatic resection. Before routine application of LCVP, operative haemorrhage during liver resection commonly led to prohibitively high morbidity and mortality rates. [3] [4] [5] [6] In addition to the morbidity and mortality associated with hypovolaemia and shock, deleterious effects in postoperative morbidity and longterm oncologic outcomes have been shown in patients receiving blood transfusions after liver resection. [7] [8] [9] [10] Although this technique has been shown to be safe and effective in reducing operative blood loss in several studies evaluating liver resection and transplantation, [11] [12] [13] [14] [15] its widespread application is still limited. Concerns have been raised about the potential for morbidity that may derive from the hypoperfusion of abdominal organs during the LCVP phase of liver resection. Specifically, the impact that the relative hypotension and potential hypoperfusion may have on kidney function have been cited as limiting factors as there is a theoretical risk for prerenal acute renal failure such as that seen in other types of operations in which splanchnic and renal circulation may be compromised. 16 The present study was conducted with the aim of evaluating renal function in a large, recent cohort of patients submitted to liver resection at a single institution at which the use of LCVP-assisted liver resection is routine in order to update this center's previously published experience. 2 This paper reports postoperative outcomes and evaluates renal function according to current classification systems based on serum creatinine and eGFR. Postoperative renal function was evaluated based on biochemical and clinical criteria and its relationship with preoperative, operative and postoperative outcomes is appraised.
Materials and methods
Institutional review board approval was obtained. The study center's institutional prospective hepatobiliary database was queried for patients submitted to liver resection under LCVP. Demographic, operative and postoperative variables were extracted. In this center's database, major liver resection is defined as resection of three or more segments according to the Couinaud classification. 17 Morbidity was extracted from the MSKCC Secondary Events Program database. To populate this database, cases were prospectively reviewed and complications recorded and graded in severity in a standardized fashion. 18 Data were pooled in a Microsoft Access database. Standard descriptive statistics were applied. Continuous data are summarized and reported as the median and interquartile range (IQR) unless otherwise specified; these variables were compared using t-tests or the Wilcoxon rank-sum test depending on the distribution. Categorical data are presented as the total number and percentage and compared using the chi-squared or Fisher's exact test depending on the number of events. A P-value of <0.05 was considered to indicate statistical significance. All statistical analyses were performed using stata Version 12.1 (StataCorp LP, College Station, TX, USA).
The MSKCC clinical laboratory database was queried to extract all laboratory results in the present patient population starting from preoperative baseline until postoperative day (POD) 14 or discharge, whichever occurred first. Glomerular Chronic kidney disease (CKD) was evaluated based on the eGFR and classified according to the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI), which measures renal function as a measure of eGFR and classifies it into stages. 20 An eGFR of ≥90 ml/min is considered normal. Subsequent interval reductions are classified as mild dysfunction (stage 2, eGFR: 60-89 ml/min), moderate dysfunction (stage 3, eGFR: 30-59 ml/min), severe dysfunction (stage 4, eGFR: 15-29 ml/min) and kidney failure (stage 5, eGFR: <15 ml/min). The degree of renal dysfunction was evaluated at baseline, at its lowest level postoperatively, and on POD 14 or at discharge. For patients who were discharged with an abnormal eGFR, creatinine levels measured at follow-up were retrieved whenever possible to evaluate for the resolution of renal dysfunction.
Furthermore, the Acute Dialysis Quality Initiative (ADQI) guidelines for the definition of acute renal failure in critically ill patients were used to evaluate the incidence of postoperative biochemical acute kidney injury (AKI) (bAKI) in this population. 21 These guidelines were used to develop the RIFLE (risk-injuryfailure-loss-end-stage) classification, which defines AKI based on the percentage change in eGFR from baseline in response to an insult and stratifies patients based on the magnitude of this change. Patients with a decrease of >25% in eGFR are considered at risk of renal dysfunction; a decrease in eGFR of >50% denotes kidney injury, and a decrease in eGFR of >75% indicates kidney failure. Loss of function and end-stage disease represent the complete loss of kidney function for >4 weeks and the presence of end-stage kidney disease (>3 months), respectively. The incidence of clinically relevant AKI was estimated from the MSKCC prospective morbidity database and graded in levels of severity. Clinical AKI (cAKI) was defined as oliguria accompanied by elevated creatinine levels.
This center's anesthetic approach to LCVP-assisted liver resection has been previously published. 1, 2 Intraoperative uid management is divided into two phases. Prehepatic resection starts at the induction of anesthesia and ends at the completion of parenchymal transection and haemostasis. During this phase, in ow control of the portal vein and hepatic artery is achieved and the vena cava and hepatic veins are dissected. Hepatic parenchymal transection is performed, during which intermittent in ow occlusion is applied (Pringle manoeuvre). This phase takes advantage of uid restriction and the vasodilatory effects of anesthetic drugs to provide LCVP. Fluid boluses and/or vasoactive drugs are administered at the discretion of the anesthesia care team to maintain systolic blood pressure (SBP) of ≥90 mmHg and urine output of >25 ml/h while maintaining the CVP at <5 mmHg. The use of central venous catheters to provide LCVP-assisted liver resection has been abandoned in this center. If visual inspection shows the retrohepatic vena cava not to have collapsed to the surgeon's satisfaction, sublingual nitroglycerine is given to the patient to assist the vasodilation of anesthetic agents. Maintenance uid is 1 ml/kg/h. The second phase, at post-hepatic resection, begins once the specimen has been delivered and haemostasis secured. During this phase, an attempt is made to return the patient to normovolaemia. Blood loss is replaced volume-to-volume with albumin or at a ratio of 3 : 1 with crystalloid. Maintenance uids are infused to achieve the assumed uid requirement 1. After this uid therapy, if SBP is <90 mmHg or urine output is <25 ml/h, additional uid boluses either colloid or crystalloid are given. Packed red blood cells are included in resuscitation if the haemoglobin level is <7 g/dl. Fresh frozen plasma or platelets may be given at the request of the surgeon if surgical haemostasis is inadequate, the international normalized ratio (INR) is 1.8-2.0, or the platelet count is <80 000 platelets/μl.
Results
A total of 2116 patients submitted to LCVP-assisted liver resection between 2003 and 2012 were identified. General demographics are presented in Table 1 . Approximately half (n = 1081, 51%) of the subjects were male, and the median patient age was 61 years (IQR: 51-70 years). The majority (57%) of patients underwent resection of colorectal liver metastases, hepatocellular carcinoma (9%) or cholangiocarcinoma (7%). Most patients had an American Society of Anesthesiologists (ASA) physical status classification score of ≤3. Only 16% of patients had a preoperative eGFR of ≥90 ml/min. The majority of the patient population (55%) had mild dysfunction (eGFR of 60-89 ml/min). None of these patients were known to have clinically significant renal disease preoperatively or were on renal replacement therapy.
In this series, most patients underwent segmental resections (30%), a formal lobectomy (24%), or single-or multiple-wedge resections (15%) ( Table 2 ). Formal sectoral resections or extended lobectomies together constituted 23% of all procedures. The median number of segments resected was two (range: one to four) and 40% of patients underwent a major resection. In two-thirds of patients (68%), a Pringle manoeuvre was used; the median Pringle time was 30 min (IQR: 23-42 min). The median estimated blood loss (EBL) was 300 ml (IQR: 200-600 ml) for the entire population and 9% of patients received a perioperative transfusion (during surgery or in the first 24 h postoperatively). Median blood loss was higher in major than in minor resections (500 ml versus 200 ml; P < 0.001) and perioperative transfusions were more common in these patients (13% versus 7%; P < 0.001). Median operating room time was 228 min (IQR: 165-299 min); the median time for major resections was 1 h longer than that for minor resections (263 min versus 200 min; P < 0.001). A total of 5% of patients (n = 100) underwent a laparoscopic resection. Only 8% of these underwent a major resection; in these patients median EBL was 100 ml (IQR: 50-163 ml) and median operative time was 148 min (IQR: 113-197 min). The postoperative dynamics of serum creatinine and eGFR across time are shown in Fig. 1 . Mean ± standard deviation (SD) values for serum creatinine in all patients were 1.0 ± 0.2 at baseline, 1.1 ± 0.5 at the postoperative peak, and 0.9 ± 0.4 at discharge. Mean ± SD eGFR values at these time-points were 71.3 ± 22.0 ml/min, 66.7 ± 20.0 ml/min and 87.0 ± 27.0 ml/min, respectively.
Postoperatively, 21% (n = 448) of patients developed at least one complication, of which half (n = 231) were major. Mortality at 90 days amounted to 2% (n = 36) and the median length of stay was 7 days (IQR: 6-9 days) ( Table 2 ). According to the RIFLE classification, 16% of patients experienced some degree of renal dysfunction (bAKI). The vast majority of these (83%) fell in the category of risk, with a reduction in their eGFR of 25-49%. Kidney injury or failure was seen in 3% of the overall population (n = 58) ( Table 2 ). Patients who underwent laparoscopic resection with LCVP (n = 100) had a 26% incidence of bAKI (n = 26); 21 of these patients were classified as at risk. Fourteen patients had a persistently low eGFR at discharge. There were no cases of clinical acute renal failure in patients submitted to laparoscopic resection.
The distribution of and final outcomes in patients who experienced bAKI are shown in Fig. 2 . Patients who maintained an eGFR of ≥90 ml/min (n = 14) were excluded from this analysis as they were considered to have normal renal function. Patients classified as at risk by the ADQI criteria had a higher likelihood of resolving their renal dysfunction by the time of discharge than those with injury or failure (50% versus 33%; P < 0.03). Overall, 47% of patients (n = 159/336) with postoperative bAKI had normal renal function by the time of discharge. Persistent dysfunction was present in 8% of the entire cohort (n = 177).
The incidence of cAKI (i.e. oliguria and elevated serum creatinine) was <1% (n = 9). All of these patients had a baseline eGFR of <90 ml/min (stage 2, n = 5; stage 3, CKD, n = 4). One patient who developed multiple organ failure secondary to liver failure required continuous renal replacement therapy; this patient died on POD 49 after 17 days of haemodialysis. Discharge eGFR was persistently low in the remaining eight patients (median: 42 ml/min; IQR: 26-59 ml/min). However, at a median of 2 months of follow-up, eGFR trended to baseline (median: 63 ml/ min; IQR: 53-100 ml/min), and three of the eight patients showed normal values. All patients returned to their baseline CKD stage category.
Baseline characteristics and operative and postoperative outcomes in patients with bAKI (excluding patients categorized as being at risk) and clinically significant renal dysfunction are presented in Table 3 and are compared with those in the rest of the patient population. Postoperative cAKI was more common in older patients and was associated with larger resections, major postoperative morbidity and longer length of hospital stay. Operative blood loss was greater in patients with cAKI, but unlike in patients with bAKI, this difference did not reach statistical significance. Interestingly, patients who ultimately developed bAKI more commonly had baseline eGFR of ≥90 ml/min (40% versus 16%; P < 0.001). 
Discussion
Low CVP-assisted liver resection takes advantage of the anesthetic manipulation of CVP to decrease operative blood loss during surgery. It has been associated with improved operative outcomes and is an established technique at certain institutions. 1, 2, [11] [12] [13] [14] [15] Acute kidney injury leading to severe or endstage renal dysfunction is a potentially devastating postoperative complication and is often cited by anesthesiologists to avoid LCVP-assisted hepatectomy. In this study, standard definitions of biochemical renal dysfunction were applied in a large series of patients submitted to LCVPassisted liver resection in the modern era. Findings showed that although biochemical alterations in renal function are relatively common, the vast majority of these patients fall into the risk category and do not develop clinically relevant dysfunction. Furthermore, alterations in eGFR are transient in nature and in 45% of patients had resolved by the time of discharge. The majority (94%) of patients with persistent biochemical alterations had mild or moderate renal dysfunction (i.e. eGFR of 30-89 ml/min). Clinically relevant postoperative AKI was very rare (<1% of the population), and was also transient and resolved during a short follow-up period in half of these patients. These results are consistent with previously published national data evaluating postoperative morbidity after liver resections 22 and other major surgeries. 23 In patients undergoing cardiac and peripheral vascular operations, which are often accompanied by intraoperative hypoperfusion, the estimated incidence of postoperative AKI is 8%, a fraction (∼1%) of which results in a requirement for renal replacement therapy. 24, 25 In this patient population, age, increased weight or body mass index, use and duration of cardiopulmonary bypass, low cardiac ejection fraction and postoperative serum creatinine dynamics have been found to be predictors of the development of acute renal failure. 25 The present investigators did not attempt to generate predictive models and did not perform any multivariate regression analysis because the incidence of the outcome of interest was low. However, postoperative renal dysfunction was more commonly seen in older patients, which is consistent with the known decrease in nephron mass that occurs with advanced age. 26 Interestingly, the prevalence of preoperative renal dysfunction was lower in patients who developed bAKI in comparison with the rest of the population.
The number of segments resected was greater in patients who developed cAKI. Nevertheless, differences in operative time and operative EBL did not reach statistical significance. These variables may be surrogate markers of not only larger resections, but also of patients with more extensive disease and higher incidences of intraoperative and postoperative complications, which are often associated with renal dysfunction.
As might be expected, postoperative renal dysfunction is associated with major morbidity and length of hospital stay. In a Department of Veterans Affairs study, 30-day mortality in patients who developed postoperative AKI requiring dialysis was 64%, compared with 4% in patients without AKI. 24 The present authors found a similarly disproportionate mortality rate in patients who developed bAKI (27%) in comparison with that (2%) in those who did not. The present study was not designed to evaluate causality as morbidity and mortality in this patient population are in uenced by many additional factors.
In addition to technical (operative and anesthetic) factors, improved perioperative care and the development of specialized units have led to improved outcomes after liver resection. 27 Over the last few decades, parenchyma-sparing resections have also improved postoperative morbidity and mortality. In a large series of patients operated on at the study institution and immediately predating the present cohort, the number of segments resected and operative blood loss were the sole factors associated with perioperative morbidity and mortality. 28 Furthermore, in the current authors' experience, perioperative complications and use of blood transfusions are also independent predictors of poor longterm oncologic outcomes. [7] [8] [9] Consequently, strategies to reduce intraoperative blood loss and perioperative transfusions are of paramount importance in patients undergoing liver resection. The present group recently completed and published two clinical trials evaluating acute normovolaemic haemodilution as a strategy to decrease the use of perioperative blood products and found this to be a useful tool in selected patients undergoing major resection. 29, 30 Trials to evaluate novel perioperative uid management strategies in patients undergoing hepatobiliary procedures are ongoing.
The present report is subject to the limitations inherent in retrospective studies. Furthermore, as the MSKCC was an early adopter of LCVP-assisted surgery, control data that allow for the comparison of the outcomes of interest are not available. However, the current data were collected in a prospective fashion and were closely monitored by well-established data management systems at the study institution and are reliable and complete. Moreover, the present group did not perform a logistic regression in order to identify factors independently associated with renal dysfunction. Although this would be useful information, the distribution of the present data and the very low incidence of the variables of interest (cAKI and persistent bAKI) would plague such an analysis with limitations and confounding factors. Thus, the current data are presented as a descriptive account and in order to update the group's experience with LCVP-assisted liver resection and the incidence of postoperative renal dysfunction.
Conclusions
Although biochemically defined renal dysfunction is a relatively common event in patients undergoing LCVP-assisted liver resection, it is a transient phenomenon and its clinical significance is limited. Clinically relevant renal dysfunction is very uncommon in this patient population, a finding that is consistent with data in the published literature regarding other types of major operation. The oversensitivity of the biochemical classification of renal dysfunction is welcome as it should alert providers to the possibility of associated adverse outcomes; however, the incidence of bAKI is not itself an argument against the use of LCVP anesthesia in liver resections.
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